VANC Pharmaceuticals Obtains NPNs For 4 Products

Life Science Investing News

VANC Pharmaceuticals Inc. (TSXV:NPH,OTCQB:NUVPF) has obtained Natural Product Number approvals for: FerroHEME (heme-iron supplement), PEDIA-SAFE drops (multivitamin dietary supplement for infant and children), SennaLax (natural laxative) and T36 Ointment (disinfectant and corticosteroid).

VANC Pharmaceuticals Inc. (TSXV:NPH,OTCQB:NUVPF) has obtained Natural Product Number approvals for: FerroHEME (heme-iron supplement), PEDIA-SAFE drops (multivitamin dietary supplement for infant and children), SennaLax (natural laxative) and T36 Ointment (disinfectant and corticosteroid).

As quoted in the press release:

Vanc plans to manufacture these products and start sales and marketing activities for them beginning in Q1-2015.

Click here to read the VANC Pharmaceuticals Inc. (TSXV:NPH,OTCQB:NUVPF) press release

The Conversation (0)
×